Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by KnowledgeBaseon Apr 07, 2021 10:02am
183 Views
Post# 32948500

I told you!

I told you!I said it the other day and I will say it again. This misstep was huge. He delivered on a promise in the worse way possible by purely printing Shares to acquire what amounts to small fish firm.   Of course the SP is going to drop. Not only are investors, ones with the shorter term goals forced to sell but it will be some time before we can recoup this cost.  SImply play this out. SP was 1.57 you devalued the Shares by collaterolizing them to the tune of 20 Million plus to acquire a firm that say has 3100 clients. OK so every client gets a test lets say ( ambitious ). 4650000 . So you would ahve to ensure the client base continues to grow or atleast remain consistant at 3100 or more a year to recoup this cost in 4-5 years. I guess thats not so bad for a long term company but its aweful considering we could ahve haed it free and clear with a partnership. Minimizing our risk. I certainly hope he has an Ace up his sleeve. This being said Im just parking my money .
<< Previous
Bullboard Posts
Next >>